About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Terumo Shifts Focus from Oxymorphone Patch to Injectables
March 20, 2018
Click here to read more
Post navigation
Previous Post
Phosphagenics Placement Secures A$1.37 million
Next Post
Phosphagenics Newsletter – March 2018
Related Posts
Phosphagenics Receives Arbitration Update from SIAC
September 4, 2018
2016 May 19 AGM Chairman and CEO Addresses
May 19, 2016
Phosphagenics Announces Results of Dairy Trial
December 22, 2017